Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Holman

Showing results (111-120 of 833) with videos related to

Pageof 84
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|February 12, 2011
Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trialH C Price, S J Griffin, R R Holman
The Journal of Clinical Investigation|August 1, 1982
Analysis of speckled fluorescent antinuclear antibody test antisera using electrofocused nuclear antigensT B Okarma, J A Krueger, H R Holman
Journal of Diabetes and Its Complications|December 13, 2002
UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetesRichard J Stevens, Irene M Stratton, Rury R Holman, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|January 1, 1988
A cognitive-behavioral treatment for rheumatoid arthritisA O'Leary, S Shoor, K Lorig, et al.
Medical Care|March 1, 1985
Chronic disease and health system performance. Care of osteoarthritis across three health servicesD P Lubeck, B W Brown, H R Holman
The New England Journal of Medicine|April 18, 1985
The relation of faculty academic activity to financing sources in a department of medicineD Chin, D Hopkins, K Melmon, et al.
Clinical Medicine (London, England)|November 5, 2009
Presenting the results of clinical trials to participantsJulie L Darbyshire, Rury R Holman, Hermione C Price
Diabetes Care|June 18, 1999
A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)R R Holman, C A Cull, R C Turner
Bioorganic & Medicinal Chemistry|February 28, 2006
Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenasesJoshua D Deschamps, Victor A Kenyon, Theodore R Holman
Lancet (London, England)|January 10, 2006
PROactive studyR R Holman, R Retnakaran, A Farmer, et al.
Pageof 84

Showing results (111-120 of 833) with videos related to

Sort By:
Pageof 84
Diabetic Medicine : a Journal of the British Diabetic Association|February 12, 2011
Impact of personalized cardiovascular disease risk estimates on physical activity-a randomized controlled trialH C Price, S J Griffin, R R Holman
The Journal of Clinical Investigation|August 1, 1982
Analysis of speckled fluorescent antinuclear antibody test antisera using electrofocused nuclear antigensT B Okarma, J A Krueger, H R Holman
Journal of Diabetes and Its Complications|December 13, 2002
UKPDS58--modeling glucose exposure as a risk factor for photocoagulation in type 2 diabetesRichard J Stevens, Irene M Stratton, Rury R Holman, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|January 1, 1988
A cognitive-behavioral treatment for rheumatoid arthritisA O'Leary, S Shoor, K Lorig, et al.
Medical Care|March 1, 1985
Chronic disease and health system performance. Care of osteoarthritis across three health servicesD P Lubeck, B W Brown, H R Holman
The New England Journal of Medicine|April 18, 1985
The relation of faculty academic activity to financing sources in a department of medicineD Chin, D Hopkins, K Melmon, et al.
Clinical Medicine (London, England)|November 5, 2009
Presenting the results of clinical trials to participantsJulie L Darbyshire, Rury R Holman, Hermione C Price
Diabetes Care|June 18, 1999
A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)R R Holman, C A Cull, R C Turner
Bioorganic & Medicinal Chemistry|February 28, 2006
Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenasesJoshua D Deschamps, Victor A Kenyon, Theodore R Holman
Lancet (London, England)|January 10, 2006
PROactive studyR R Holman, R Retnakaran, A Farmer, et al.
Pageof 84